1

Usually water or low-molecular-weight alcohols or compounds, used in topical applications and in wet granulation, for the production of tablets.

moistening agents

1

Usually water or low-molecular-weight alcohols or compounds, used in topical applications and in wet granulation, for the production of tablets.

moistening agents

2

Dosage form comprising several elements (e.g., microspheres or coated pellets) dif- fering in the rate of drug release.

multi compartment formulation

2

Dosage form comprising several elements (e.g., microspheres or coated pellets) dif- fering in the rate of drug release.

multi compartment formulation

3

Consists of several different layers that are compressed on top of each other, to form a single tablet composed of two or more layers.

multilayer tablet

3

Consists of several different layers that are compressed on top of each other, to form a single tablet composed of two or more layers.

multilayer tablet

4

Device that disperses liquids to aerosols for therapeutic use by inhalation through a mask.

nebulizer

4

Device that disperses liquids to aerosols for therapeutic use by inhalation through a mask.

nebulizer

5

Greasy, semi-solid preparation for external application, often anhydrous, containing dissolved or dispersed medicaments.

ointment

5

Greasy, semi-solid preparation for external application, often anhydrous, containing dissolved or dispersed medicaments.

ointment

6

Kinetic model, where the whole body is thought of as a single compartment in which a substance is dis- tributed rapidly, achieving an equilibrium between blood and tissue immediately.

one-compartment model

6

Kinetic model, where the whole body is thought of as a single compartment in which a substance is dis- tributed rapidly, achieving an equilibrium between blood and tissue immediately.

one-compartment model

7

Time required to achieve the minimum effective plasma concentration following administration of the dosage form.

onset of drug action

7

Time required to achieve the minimum effective plasma concentration following administration of the dosage form.

onset of drug action

8

Process of agglomeration that converts fine powders or granules of bulk drugs and excipients into small, free-flowing, spherical, or semi-spherical units, referred to as pellets.

pelletization

8

Process of agglomeration that converts fine powders or granules of bulk drugs and excipients into small, free-flowing, spherical, or semi-spherical units, referred to as pellets.

pelletization

9

Science of preparation of drugs, dosage forms, and drug delivery systems taking into account the pharmacokinetics and pharmacodynamics of the drug as well as its physical and chemical properties.

pharmaceutics

9

Science of preparation of drugs, dosage forms, and drug delivery systems taking into account the pharmacokinetics and pharmacodynamics of the drug as well as its physical and chemical properties.

pharmaceutics

10

Solid material that exists at least in two different molecular arrangements, i.e., distinctly different crystal species.

polymorph

10

Solid material that exists at least in two different molecular arrangements, i.e., distinctly different crystal species.

polymorph

11

Transition of a solid crystalline phase to another phase having the same chemical composition but a dif- ferent crystal structure.

polymorphic transition

11

Transition of a solid crystalline phase to another phase having the same chemical composition but a dif- ferent crystal structure.

polymorphic transition

12

Existence of two or more different crystal structures for the same compound.

polymorphism

12

Existence of two or more different crystal structures for the same compound.

polymorphism

13

Defined for powders used pharmaceutically, according to particle sizes.


powder grades

13

Defined for powders used pharmaceutically, according to particle sizes.


powder grades

14

Dry solid material consisting of many, usually free flowing, fine particles.

powder

14

Dry solid material consisting of many, usually free flowing, fine particles.

powder

15

Exploratory activity that begins early in pharmaceutics, involving studies designed to determine the compatibility of excipients with the active substance for a biopharmaceutical; physicochemical and bioanalytical investigation 


preformulation

15

Exploratory activity that begins early in pharmaceutics, involving studies designed to determine the compatibility of excipients with the active substance for a biopharmaceutical; physicochemical and bioanalytical investigation 


preformulation

You may also like